Cargando…

Antiviral activity of four types of bioflavonoid against dengue virus type-2

BACKGROUND: Dengue is a major mosquito-borne disease currently with no effective antiviral or vaccine available. Effort to find antivirals for it has focused on bioflavonoids, a plant-derived polyphenolic compounds with many potential health benefits. In the present study, antiviral activity of four...

Descripción completa

Detalles Bibliográficos
Autores principales: Zandi, Keivan, Teoh, Boon-Teong, Sam, Sing-Sin, Wong, Pooi-Fong, Mustafa, Mohd Rais, AbuBakar, Sazaly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3271998/
https://www.ncbi.nlm.nih.gov/pubmed/22201648
http://dx.doi.org/10.1186/1743-422X-8-560
_version_ 1782222771151962112
author Zandi, Keivan
Teoh, Boon-Teong
Sam, Sing-Sin
Wong, Pooi-Fong
Mustafa, Mohd Rais
AbuBakar, Sazaly
author_facet Zandi, Keivan
Teoh, Boon-Teong
Sam, Sing-Sin
Wong, Pooi-Fong
Mustafa, Mohd Rais
AbuBakar, Sazaly
author_sort Zandi, Keivan
collection PubMed
description BACKGROUND: Dengue is a major mosquito-borne disease currently with no effective antiviral or vaccine available. Effort to find antivirals for it has focused on bioflavonoids, a plant-derived polyphenolic compounds with many potential health benefits. In the present study, antiviral activity of four types of bioflavonoid against dengue virus type -2 (DENV-2) in Vero cell was evaluated. Anti-dengue activity of these compounds was determined at different stages of DENV-2 infection and replication cycle. DENV replication was measured by Foci Forming Unit Reduction Assay (FFURA) and quantitative RT-PCR. Selectivity Index value (SI) was determined as the ratio of cytotoxic concentration 50 (CC(50)) to inhibitory concentration 50 (IC(50)) for each compound. RESULTS: The half maximal inhibitory concentration (IC(50)) of quercetin against dengue virus was 35.7 μg mL(-1 )when it was used after virus adsorption to the cells. The IC(50 )decreased to 28.9 μg mL(-1 )when the cells were treated continuously for 5 h before virus infection and up to 4 days post-infection. The SI values for quercetin were 7.07 and 8.74 μg mL(-1), respectively, the highest compared to all bioflavonoids studied. Naringin only exhibited anti-adsorption effects against DENV-2 with IC(50 )= 168.2 μg mL(-1 )and its related SI was 1.3. Daidzein showed a weak anti-dengue activity with IC(50 )= 142.6 μg mL(-1 )when the DENV-2 infected cells were treated after virus adsorption. The SI value for this compound was 1.03. Hesperetin did not exhibit any antiviral activity against DENV-2. The findings obtained from Foci Forming Unit Reduction Assay (FFURA) were corroborated by findings of the qRT-PCR assays. Quercetin and daidzein (50 μg mL(-1)) reduced DENV-2 RNA levels by 67% and 25%, respectively. There was no significant inhibition of DENV-2 RNA levels with naringin and hesperetin. CONCLUSION: Results from the study suggest that only quercetin demonstrated significant anti-DENV-2 inhibitory activities. Other bioflavonoids, including daidzein, naringin and hesperetin showed minimal to no significant inhibition of DENV-2 virus replication. These findings, together with those previously reported suggest that select group of bioflavonoids including quercetin and fisetin, exhibited significant inhibitory activities against dengue virus. This group of flavonoids, flavonol, could be investigated further to discover the common mechanisms of inhibition of dengue virus replication.
format Online
Article
Text
id pubmed-3271998
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32719982012-02-04 Antiviral activity of four types of bioflavonoid against dengue virus type-2 Zandi, Keivan Teoh, Boon-Teong Sam, Sing-Sin Wong, Pooi-Fong Mustafa, Mohd Rais AbuBakar, Sazaly Virol J Research BACKGROUND: Dengue is a major mosquito-borne disease currently with no effective antiviral or vaccine available. Effort to find antivirals for it has focused on bioflavonoids, a plant-derived polyphenolic compounds with many potential health benefits. In the present study, antiviral activity of four types of bioflavonoid against dengue virus type -2 (DENV-2) in Vero cell was evaluated. Anti-dengue activity of these compounds was determined at different stages of DENV-2 infection and replication cycle. DENV replication was measured by Foci Forming Unit Reduction Assay (FFURA) and quantitative RT-PCR. Selectivity Index value (SI) was determined as the ratio of cytotoxic concentration 50 (CC(50)) to inhibitory concentration 50 (IC(50)) for each compound. RESULTS: The half maximal inhibitory concentration (IC(50)) of quercetin against dengue virus was 35.7 μg mL(-1 )when it was used after virus adsorption to the cells. The IC(50 )decreased to 28.9 μg mL(-1 )when the cells were treated continuously for 5 h before virus infection and up to 4 days post-infection. The SI values for quercetin were 7.07 and 8.74 μg mL(-1), respectively, the highest compared to all bioflavonoids studied. Naringin only exhibited anti-adsorption effects against DENV-2 with IC(50 )= 168.2 μg mL(-1 )and its related SI was 1.3. Daidzein showed a weak anti-dengue activity with IC(50 )= 142.6 μg mL(-1 )when the DENV-2 infected cells were treated after virus adsorption. The SI value for this compound was 1.03. Hesperetin did not exhibit any antiviral activity against DENV-2. The findings obtained from Foci Forming Unit Reduction Assay (FFURA) were corroborated by findings of the qRT-PCR assays. Quercetin and daidzein (50 μg mL(-1)) reduced DENV-2 RNA levels by 67% and 25%, respectively. There was no significant inhibition of DENV-2 RNA levels with naringin and hesperetin. CONCLUSION: Results from the study suggest that only quercetin demonstrated significant anti-DENV-2 inhibitory activities. Other bioflavonoids, including daidzein, naringin and hesperetin showed minimal to no significant inhibition of DENV-2 virus replication. These findings, together with those previously reported suggest that select group of bioflavonoids including quercetin and fisetin, exhibited significant inhibitory activities against dengue virus. This group of flavonoids, flavonol, could be investigated further to discover the common mechanisms of inhibition of dengue virus replication. BioMed Central 2011-12-28 /pmc/articles/PMC3271998/ /pubmed/22201648 http://dx.doi.org/10.1186/1743-422X-8-560 Text en Copyright ©2011 Zandi et al; licensee BioMed Central Ltd http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Zandi, Keivan
Teoh, Boon-Teong
Sam, Sing-Sin
Wong, Pooi-Fong
Mustafa, Mohd Rais
AbuBakar, Sazaly
Antiviral activity of four types of bioflavonoid against dengue virus type-2
title Antiviral activity of four types of bioflavonoid against dengue virus type-2
title_full Antiviral activity of four types of bioflavonoid against dengue virus type-2
title_fullStr Antiviral activity of four types of bioflavonoid against dengue virus type-2
title_full_unstemmed Antiviral activity of four types of bioflavonoid against dengue virus type-2
title_short Antiviral activity of four types of bioflavonoid against dengue virus type-2
title_sort antiviral activity of four types of bioflavonoid against dengue virus type-2
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3271998/
https://www.ncbi.nlm.nih.gov/pubmed/22201648
http://dx.doi.org/10.1186/1743-422X-8-560
work_keys_str_mv AT zandikeivan antiviralactivityoffourtypesofbioflavonoidagainstdenguevirustype2
AT teohboonteong antiviralactivityoffourtypesofbioflavonoidagainstdenguevirustype2
AT samsingsin antiviralactivityoffourtypesofbioflavonoidagainstdenguevirustype2
AT wongpooifong antiviralactivityoffourtypesofbioflavonoidagainstdenguevirustype2
AT mustafamohdrais antiviralactivityoffourtypesofbioflavonoidagainstdenguevirustype2
AT abubakarsazaly antiviralactivityoffourtypesofbioflavonoidagainstdenguevirustype2